Pamela J. Cramer sold $478K of Rhythm Pharmaceuticals (RYTM)

Executed Jun 6 2025, disclosed Jun 10 2025, 4 days later.

Value, as filed

$478K

7,031 sh × $68.05

Executed

Jun 6 2025

the trade date, as filed

Disclosed

Jun 10 2025

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

PC Pamela J. Cramer Chief Human Resources Officer profile →

Pamela J. Cramer (Chief Human Resources Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Rhythm Pharmaceuticals, Inc. (RYTM). The largest single filing was $2.3M of RYTM (22,866 sh across 2 lots, as filed), executed Nov 7 2025.

The name

RYTM Rhythm Pharmaceuticals, Inc. RYTM · Healthcare · 47 filings in 24 months ticker →

Healthcare · Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases in the United State…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Pamela J. Cramer in RYTM

RYTMSALE Rhythm Pharmaceuticals, Inc. $372K
3,350 sh × $111.00
Exec Dec 11 2025
Filed Dec 15 2025 · 5:30 PM ET RYTMSALE Rhythm Pharmaceuticals, Inc. $352K
3,350 sh × $105.00
Exec Nov 20 2025
Filed Nov 24 2025 · 5:30 PM ET RYTMSALE Rhythm Pharmaceuticals, Inc. $2.3M
22,866 sh across 2 lots
Exec Nov 7 2025
Filed Nov 12 2025 · 5:30 PM ET RYTMSALE Rhythm Pharmaceuticals, Inc. $131K
1,520 sh × $85.93
Exec Jul 29 2025
Filed Jul 29 2025 · 5:30 PM ET RYTMSALE Rhythm Pharmaceuticals, Inc. $1.2M
15,572 sh across 3 lots
Exec Jul 9 2025
Filed Jul 11 2025 · 5:30 PM ET RYTMSALE Rhythm Pharmaceuticals, Inc. $458K
7,031 sh × $65.09
Exec Apr 29 2025
Filed May 1 2025 · 5:30 PM ET RYTMSALE Rhythm Pharmaceuticals, Inc. $1.2M
20,160 sh across 3 lots
Exec Apr 8 2025
Filed Apr 10 2025 · 5:30 PM ET RYTMSALE Rhythm Pharmaceuticals, Inc. $586K
9,375 sh across 2 lots
Exec Nov 6 2024
Filed Nov 8 2024 · 5:30 PM ET